RG7388: Translational Leverage for p53 Pathway Modulation in
2026-06-25
This thought-leadership article delivers an in-depth exploration of RG7388, a next-generation oral MDM2 antagonist, providing translational researchers with mechanistic insights and strategic guidance for advancing p53-driven cancer research. By integrating recent discoveries around the MDM1-p53 axis and highlighting actionable protocol recommendations, we bridge cutting-edge evidence with practical workflows, positioning RG7388 as a cornerstone for combination therapy innovation and biomarker-driven oncology.
O-GlcNAcylation Directs Wnt-Induced Glycolysis in Bone Forma
2026-06-25
You et al. (2024) reveal that Wnt3a signaling drives bone anabolism by rapidly and sustainably increasing protein O-GlcNAcylation, which stabilizes PDK1 and rewires glycolysis in osteoblasts. These insights clarify metabolic mechanisms underpinning osteogenesis and point to O-GlcNAcylation as a potential therapeutic target for osteoporosis and fracture healing.
Cy5 amine (non-sulfonated): Technical Guide for Fluorescent
2026-06-24
Cy5 amine (non-sulfonated) addresses the need for a bright, photostable fluorescent probe suitable for covalent labeling of proteins, peptides, and polymers in research workflows where water-insoluble dyes are preferred. It is not intended for direct aqueous labeling or any diagnostic or medical use, and requires specific handling procedures to ensure labeling efficiency.
SB203580: Translating Mechanistic Precision Into p38 MAPK Re
2026-06-23
This thought-leadership article explores how SB203580 (4-[4-(4-fluorophenyl)-2-(4-methylsulfinylphenyl)-1H-imidazol-5-yl]pyridine) enables translational researchers to dissect and modulate the p38 MAPK pathway with unprecedented mechanistic clarity. Bridging recent neuroinflammation findings and advanced regenerative workflows, the piece delivers actionable protocol insights, competitive context, and a forward-looking vision for integrative MAPK research strategies.
TAK1 Stabilizes YAP to Drive Gastric Cancer Stem Cell Renewa
2026-06-23
This study demonstrates that TGFβ-activated kinase 1 (TAK1) directly stabilizes yes-associated protein (YAP), promoting self-renewal and oncogenic potential in gastric cancer stem cells. The findings clarify a key molecular mechanism underlying tumorigenesis and highlight new avenues for targeted intervention in gastric cancer.
I-BET-762 (SKU B1498): Reliable BET Inhibition for Lab Assay
2026-06-22
This article provides scenario-driven, evidence-backed guidance for deploying I-BET-762 (SKU B1498) as a selective BET inhibitor in cell viability, proliferation, and cytotoxicity assays. Researchers will find practical protocols, comparative insights, and troubleshooting advice to ensure reproducibility and mechanistic clarity with I-BET-762 in cancer biology and inflammation research.
ARCA Cy5 EGFP mRNA (5-moUTP): Illuminating mRNA Delivery Kin
2026-06-22
Explore how ARCA Cy5 EGFP mRNA (5-moUTP) transforms mRNA delivery and localization studies with advanced 5-methoxyuridine modification. Uncover the science behind its unique design and practical advantages for mRNA localization and translation efficiency assays.
EdU Cell Proliferation Kit (TMB): Precision S-Phase Detectio
2026-06-21
The EdU Cell Proliferation Kit (TMB) enables highly specific measurement of cell proliferation using 5-ethynyl-2'-deoxyuridine, offering a non-radioactive, chromogenic alternative to BrdU or tritiated thymidine assays. Its click chemistry mechanism ensures low background and accurate S-phase detection, supporting advanced research applications in genotoxicity and pharmacodynamics.
Combinational EZH2, eIF4F, and AKT1 Inhibition in BRAF-Mutan
2026-06-20
This study reveals that simultaneously targeting the eIF4F complex, AKT1, and EZH2 can overcome drug resistance in BRAFV600E mutant melanoma cells. The findings support combinational epigenetic and signaling pathway inhibition as a promising strategy to enhance anticancer efficacy and address resistance mechanisms.
Gap19: A Selective Connexin 43 Hemichannel Blocker for Neuro
2026-06-19
Gap19 distinguishes itself as a selective connexin 43 hemichannel blocker, enabling precise modulation of neuroglial and immune signaling in both in vitro and in vivo models. Its high selectivity, robust solubility, and literature-backed efficacy make it the tool of choice for stroke, neuroprotection, and macrophage polarization research.
FH1 Small Molecule (B3700): Enhancing iPS Hepatocyte Maturat
2026-06-19
FH1, a small molecule from APExBIO, accelerates iPS cell differentiation into mature hepatocyte-like cells, doubling albumin secretion and increasing CYP3A4 levels in culture. This product enables robust hepatic models for research and is verifiably benchmarked for cultured hepatocyte function enhancement.
TAI-1 Hec1 Inhibitor: High-Precision Cancer Research Workflo
2026-06-18
TAI-1, a first-in-class Hec1 inhibitor, delivers unmatched potency and selectivity for disrupting mitotic regulation in cancer cells. This guide details stepwise protocols, practical troubleshooting, and advanced applications—empowering researchers to drive innovation in cancer cell proliferation inhibition and apoptotic cell death induction.
WEHI-539: Potent BCL-XL Inhibitor for Advanced Apoptosis Res
2026-06-18
WEHI-539, a highly selective BCL-XL inhibitor, enables researchers to precisely dissect apoptosis pathways and overcome stem cell-driven chemoresistance in cancer models. This article delivers a deep dive into experimental workflows, protocol parameters, and troubleshooting strategies, empowering apoptosis research with robust, reproducible outcomes.
Rifampin in Bacterial Resistance Mechanism Research
2026-06-17
Rifampin, a powerful rifamycin antibiotic, is indispensable for researchers investigating bacterial resistance, transcriptional regulation, and synthetic biology. This guide translates bench protocol optimization, troubleshooting, and practical workflow tips into actionable insights, anchored in data-driven evidence and cross-resource expertise.
Annexin V-FITC/7-AAD Apoptosis Kit: Technical Application Gu
2026-06-17
The Annexin V-FITC/7-AAD Apoptosis Kit enables rapid, dual-parameter detection of apoptotic and necrotic cells in cell death and viability workflows. It is best suited for use with fluorescence microscopy or flow cytometry, but not for mechanistic apoptosis pathway studies or non-standard cell death forms. Users should follow established protocols and recognize the kit's application boundaries.
460 records 14/31 page Previous Next First page 上5页 1112131415 下5页 Last page